BMS-1
PD1-PD-L1 inhibitor 1 (PD1-PD-L1-IN-1) is an inhibitor of the PD1-PD-L1 protein-protein interaction. It also acts as an immunomodulator. Programmed death ligand 1 (PD-L1) is a protein in humans that is encoded by the CD274 gene and the upregulation of PD-L1 allows Ys to evade the host immune system. High tumor expression of PD-L1 was associated with increased tumor aggressiveness and a 4.5-fold increased risk of death.
| Catalog Number | T3655 |
| Alternative Name(s) | PD-1/PD-L1 inhibitor 1 , PD1-PDL1 inhibitor 1 |
| Research Area | Immunology/Inflammation|||Apoptosis|||Cell Cycle/Checkpoint |
| Molecular Formula | C29H33NO5 |
| CAS# | 1675201-83-8 |
| Purity | 99.81% |
| SMILES | COc1cc(OCc2cccc(-c3ccccc3)c2C)cc(OC)c1CN1CCCC[C@H]1C(O)=O |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/BMS-1 |
| Additional Information | https://www.targetmol.com/datasheet/T3655 |
